
HIV Protease
HIV Protease inhibitors are a class of antiretroviral drugs that specifically target the protease enzyme of the Human Immunodeficiency Virus (HIV). By inhibiting this enzyme, these compounds prevent the virus from processing its polyproteins into mature, functional proteins, thereby blocking the production of new infectious virions. HIV Protease inhibitors are a cornerstone of highly active antiretroviral therapy (HAART) used to manage HIV/AIDS. At CymitQuimica, we provide a variety of HIV Protease inhibitors to support your research in HIV treatment, drug resistance, and virology.
Found 506 products of "HIV Protease"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Acetyl-pepstatin
CAS:Streptomyces pepsin inhibitor is used as a pepsin inhibitor.Formula:C31H57N5O9Color and Shape:SolidMolecular weight:643.81Peptide T
CAS:Peptide T, an HIV-1 derived octapeptide, may inhibit gp120 binding to CD4 and cytokines, and affect VIP receptors.Formula:C35H55N9O16Purity:98%Color and Shape:SolidMolecular weight:857.86BNM-III-170
CAS:BNM-III-170 is able to inhibit HIV-1 viral entry into target cells.Formula:C25H26ClF7N6O6Color and Shape:SolidMolecular weight:674.96MPG, HIV related
CAS:MPG: 27-amino acid peptide from HIV-1 gp41 & SV40 T antigen, delivers nucleic acids into cells efficiently.Formula:C126H201N35O33SPurity:98%Color and Shape:SolidMolecular weight:2766.22ICeD-2
ICeD-2 triggers death in HIV-1 infected cells, requires HIV protease, inhibits DPP8/9, and stabilizes DPP9 in PBMCs.Formula:C20H29N3OColor and Shape:SolidMolecular weight:327.46Globotriaosylceramides (porcine)
CAS:Globotriaosylceramides, cell membrane glycosphingolipids, act as Shiga toxin receptors and accumulate in Fabry disease, resisting HIV by blocking gp120.Formula:C60H113NO18Color and Shape:SolidMolecular weight:1136.553Elvucitabine
CAS:Elvucitabine, a reverse transcriptase inhibitor, is used potentially for the treatment of HBV infection and HIV infection.Formula:C9H10FN3O3Color and Shape:SolidMolecular weight:227.19BMS-955176 TFA
CAS:GSK3532795: Oral HIV-1 maturation inhibitor, broad virus coverage, EC50: 15 nM, good preclinical pharmacokinetics.Formula:C44H64N2O8SPurity:98%Color and Shape:SolidMolecular weight:781.06HIV-1 protease-IN-10
HIV-1 protease-IN-10 (Compound 2), exhibiting HIV-1 latency reversing activity (IC50: 0.22 μM), selectively binds to the PKCδ C1b domain (IC50: 0.69 μM) andFormula:C23H40O5Purity:98%Color and Shape:SolidMolecular weight:396.56(2S,5S)-Censavudine
(2S,5S)-Censavudine, a potent HIV inhibitor and nucleoside reverse transcriptase blocker.Formula:C12H12N2O4Color and Shape:SolidMolecular weight:248.23L 754394
CAS:L 754394 is an effective and specific inhibitor of the HIV-1 protease.Formula:C38H47N5O5Color and Shape:SolidMolecular weight:653.81CI-39
CAS:CI-39, an NNRTI with EC50 of 3.40 µM, inhibits HIV-1 reverse transcriptase and RNase H, with CC50 >30 µM.Formula:C19H18N2O4Color and Shape:SolidMolecular weight:338.36QYL-685
CAS:QYL-685 is a methylenecyclopropane nucleoside analog.Formula:C20H24N7O5PColor and Shape:SolidMolecular weight:473.42UK-88947 HCl
CAS:UK 88947 is a protease inhibitor.Formula:C41H63ClN6O6Purity:98%Color and Shape:SolidMolecular weight:771.44Clavirolide L
Clavirolide L (Compound 3), a dolabellane-type diterpenoid isolated from Clavularia viridis, demonstrates significant inhibition against HIV-1 withoutFormula:C20H28O3Color and Shape:SolidMolecular weight:316.43Decanoyl-RVKR-CMK
CAS:Inhibits all seven proprotein convertases; stops proET-1 processing; hinders VGF secretion in PC12 cells.Formula:C34H66ClN11O5Purity:98%Color and Shape:SolidMolecular weight:744.42Tenofovir-C3-O-C15-CF3 ammonium
CAS:Tenofovir-C3-O-C15-CF3 (ammonium) has a longer half-life and stronger anti-HIV action, improving pharmacokinetics in vivo.Formula:C28H52F3N6O5PColor and Shape:SolidMolecular weight:640.73JE-2178
CAS:JE-2178 is compound with high bioavailability .Formula:C35H51N5O6SColor and Shape:SolidMolecular weight:669.87Tenofovir-C3-O-C12-trimethylsilylacetylene ammonium
CAS:Tenofovir-C3-O-C12 has a longer half-life, potent anti-HIV effects, and better pharmacokinetics than tenofovir.Formula:C29H55N6O5PSiColor and Shape:SolidMolecular weight:626.855AL-470
CAS:AL-470 demonstrates significant antiviral efficacy, exhibiting EC50 values of 0.27 µM against HIV-1, 0.63 µM against HIV-2, and 0.35 µM against EV-A71, asFormula:C67H57N7O23Color and Shape:SolidMolecular weight:1328.2

